Author:
Wei Ming-gang,Sun Wei,Xiong Pei-hua,Shao Jia-de
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Complementary and alternative medicine,General Medicine
Reference22 articles.
1. Gabbiani G. The biology of the myofibroblast. Kidney Int 1992;41:530–532.
2. Muchaneta-Kubara EC, el Nahas AM. Myofibroblast phenotypes expression in experimental renal scarring. Nephrol Dial Transplant 1997;12:905–915.
3. Jerums G, Panagiotopoulos S, Tsalamandris C, Allen TJ, Gilbert RE, Comper WD. Why is proteinuria such an important risk factor for progression in clinical trial? Kidney Int 1997;52:S87–S92.
4. Rysz J, Pedzik A, Markuszewski L, Kujawski K, Blaszczak R, Olszewski R. The role of metalloproteinases in kidney pathophysiology. Pol Merkur Lekarski (Polish) 2005;19:812–815.
5. Ahmed AK, Haylor JL, El Nahas AM, Johnson TS. Localization of matrix metalloproteinases and their inhibitors in experimental progressive kidney scarring. Kidney Int 2007;71:755–763.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献